The number of people with susceptibility test result for rifampicin in Liberia
Liberia: The number of people with susceptibility test result for rifampicin was 37.16 in 2021. ▼ Falling
Latest (2021)
37.16
Change on year
up 52.3%
World rank
126th
of 146 countries
All-time high
42.28
in 2019
All-time low
22.57
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Liberia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Liberia stood at 37.16.
The figure is up 52.3% on the previous year and down 10.2% over five years.
That places Liberia 126th out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Liberia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 41.4 | — |
| 2018 | 22.57 | -45.5% |
| 2019 | 42.28 | +87.4% |
| 2020 | 24.4 | -42.3% |
| 2021 | 37.16 | +52.3% |
Liberia compared with similar countries
- Liberia's 37.16 is above the median for low income countries, which is 37.16, 1.0× the median. (13 countries reporting)
- Liberia's 37.16 is below the median for Sub-Saharan Africa, which is 61.16, 61% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 35.42 | 22.57 | 42.28 | 3 |
| 2020s | 30.78 | 24.4 | 37.16 | 2 |
Countries ranked near Liberia
More health data for Liberia
- Un projection of annual infant deaths, annual growth rate -1.57 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7528 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,097 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,457 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 7 (2025)
- Population ages 00-04, female, annual growth rate 1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.068 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.13 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Liberia?
- The number of people with susceptibility test result for rifampicin in Liberia was 37.16 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Liberia?
- The highest recorded value was 42.28 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Liberia?
- The lowest recorded value was 22.57 in 2018.
- How does Liberia rank for the number of people with susceptibility test result for rifampicin?
- Liberia ranks 126th out of 146 countries with data for 2021.
- Where does this Liberia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).